We are live on ! Find out more
EPZM

Epizyme, Inc

Delisted

EPZM was delisted on the 11th of August, 2022.

134 hedge funds and large institutions have $1B invested in Epizyme, Inc in 2019 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 53 increasing their positions, 27 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 27

80% more funds holding in top 10

Funds holding in top 10: 59 (+4)

68% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 22

11% more funds holding

Funds holding: 121134 (+13)

4% more capital invested

Capital invested by funds: $965M → $1B (+$38M)

67% less call options, than puts

Call options by funds: $687K | Put options by funds: $2.1M

Holders
134
Holders Change
+13
Holders Change %
+10.74%
% of All Funds
2.91%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.2%
New
37
Increased
53
Reduced
27
Closed
22
Calls
$687K
Puts
$2.1M
Net Calls
-$1.42M
Net Calls Change
-$369K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$1.5M +$365K +28,342 +31%
Ameriprise
52
Ameriprise
Minnesota
$1.46M +$1.5M +116,300 New
OAM
53
Oxford Asset Management
United Kingdom
$1.42M +$45.5K +3,533 +3%
Bank of America
54
Bank of America
North Carolina
$1.38M +$572K +44,443 +68%
AG
55
Algert Global
California
$1.36M +$1.39M +108,196 New
AllianceBernstein
56
AllianceBernstein
Tennessee
$1.35M +$371K +28,800 +36%
Wells Fargo
57
Wells Fargo
California
$1.19M +$223K +17,308 +22%
UBS Group
58
UBS Group
Switzerland
$1.16M +$514K +39,978 +76%
State of Wisconsin Investment Board
59
State of Wisconsin Investment Board
Wisconsin
$1.09M +$79.8K +6,200 +8%
Bank of Montreal
60
Bank of Montreal
Ontario, Canada
$1.03M +$1.06M +82,272 New
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$999K +$365K +28,400 +55%
PCM
62
Prelude Capital Management
New York
$912K +$923K +71,755 +7,593%
Citigroup
63
Citigroup
New York
$858K +$652K +50,680 +286%
WMSA
64
Weiss Multi-Strategy Advisers
New York
$816K -$129K -10,000 -13%
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
$798K +$818K +63,569 New
Allianz Asset Management
66
Allianz Asset Management
Germany
$784K +$804K +62,518 New
FAM
67
Fred Alger Management
New York
$715K +$605K +47,000 +470%
Federated Hermes
68
Federated Hermes
Pennsylvania
$699K +$707K +54,944 +7,080%
TTSTC
69
Texas Treasury Safekeeping Trust Company
Texas
$663K +$68K +5,287 New
CS
70
Credit Suisse
Switzerland
$640K -$238K -18,529 -27%
Barclays
71
Barclays
United Kingdom
$634K +$283K +21,978 +77%
OPPM
72
Opus Point Partners Management
New York
$632K
AIG
73
American International Group
New York
$620K +$147K +11,386 +30%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$613K +$113K +8,818 +22%
BFM
75
Boothbay Fund Management
New York
$596K +$611K +47,474 New

EPZM Hedge Fund Activity: Q2 2019 in Review

134 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2019, worth a combined $1B — up 3.9% from $965M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new EPZM positions and 22 closed out — a net gain of 15 holders — while 53 added to existing stakes and 27 trimmed.

The largest buyer was Vanguard Group, adding an estimated $21M. The largest seller was NEA Management Company, cutting an estimated $32.2M.

  • 134 institutional investors held Epizyme, Inc (EPZM) as of Q2 2019, up from 121 in Q1 2019.
  • Funds reported $1B of Epizyme, Inc stock for Q2 2019, up 3.9% quarter-over-quarter.
  • 37 funds opened new Epizyme, Inc positions in Q2 2019 and 22 closed out, a net change of +15 holders.
  • The largest Epizyme, Inc buyer in Q2 2019 was Vanguard Group, an estimated $21M added.
  • The largest Epizyme, Inc seller in Q2 2019 was NEA Management Company, an estimated $32.2M sold.

Based on aggregated 13F filings for Q2 2019.